Home » Provectus Receives Indian Patent for Cancer Drug
Provectus Receives Indian Patent for Cancer Drug
Tennessee-based Provectus Pharmaceuticals has received a patent in India for its cancer drug PV-10.
The patent covers capsules, tablets, injectable formulations and oral suspensions and solutions, Provectus said.
The company is conducting Phase II trials on PV-10 as a treatment for melanoma and breast cancer.
Upcoming Events
-
07May
-
14May
-
23May
-
30May
-
20Jun
-
21Oct